Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Crazy eights

Crazy eights

Crazy eights
Eight profitable biotech and pharma companies that have Street estimates all beat the consensus numbers last week. Moreover, four companies - Biosite (BSTE), Connetics (CNCT), Gilead (GILD) and Shire (LSE:SHP; SHPGY) - beat their numbers by at least $0.10. The one disappointment was Bristol-Myers (BMY), which expects 2005 and 2006 EPS to be lower than Street predictions. Mcap in $M. (A) Results for fiscal fourth quarter.
Company 2Q04EPS est 2Q04 EPS actual Outcome Growth from 2Q03 7/30

Read the full 883 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers